Epidemiological studies suggest that RPA reduces the risk of developing depression in those with diabetes by enhancing insulin sensitivity and glucose uptake, improving cardiovascular fitness and blood pressure regulation, and decreasing inflammation [25,26]. The gene discussed is INS; the disease is depressive disorder.